Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors.
Crean-Tate KK, Braley C, Dey G, Esakov E, Saygin C, Trestan A, Silver DJ, Turaga SM, Connor EV, DeBernardo R, Michener CM, Rose PG, Lathia J, Reizes O.
Crean-Tate KK, et al. Among authors: michener cm.
J Ovarian Res. 2021 Apr 22;14(1):55. doi: 10.1186/s13048-021-00797-x.
J Ovarian Res. 2021.
PMID: 33888137
Free PMC article.